Effects of doses of fragment (25-35) of β-amyloid peptide on behavior in rats

Neuroscience and Behavioral Physiology

Volumn 28, Issue 5, 1998, Pages 564-566

  Stepanichev, M Yu ^a   Lazareva, N A ^a   Onufriev, M V ^a   Mitrokhina, O S ^a   Moiseeva, Yu V ^a   Gulyaeva, N V ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (35 25); AMYLOID BETA-PROTEIN (35-25); PEPTIDE FRAGMENT;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; ESCAPE BEHAVIOR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; RAT; SHORT TERM MEMORY; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; ESCAPE REACTION; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY, SHORT-TERM; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 0032150785     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02463018     Document Type: Article

References (6)

1. Ya. Buresh, O. Bureshova, and J. P. Houston, Methods and Basic Experiments for the Study of the Brain and Behavior [in Russian], Vysshaya Shkola, Moscow (1991).
2. N. V. Gulyaeva, N. A. Lazareva, M. L. Libe, et al., "Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A)," Brain Res., 726, 174 (1996).
3. T. Maurice, B. P. Lockhart, and A. Privat, "Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction," Brain Res., 706, 181 (1996).
4. T. A. Perry, E. Torres, C. Czech, et al., "Cognitive and motor function in transgenic mice carrying excess copies of the 695 and 751 amino acid isoforms of the amyloid protein precursor gene," Alzheimer's Research, 1, No. 1, 5 (1995).
5. M. Sarter, G. Bodewitz, and D. N. Stephens, "Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist of β-carbolines," Psychopharmacology, 94, 491 (1988).
6. D. J. Selkoe, "The molecular pathology of Alzheimer's disease," Neuron, 6, 487 (1991).